Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens-Reference-Cited by-同舟云学术

Genetic Polymorphisms of IL28B and PNPLA3 Are Predictive for HCV Related Rapid Fibrosis Progression and Identify Patients Who Require Urgent Antiviral Treatment with New Regimens

Published:2015-09-09 Issue:9 Volume:10 Page:e0137351
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tamaki Nobuharu,Kurosaki Masayuki,Higuchi Mayu,Takada Hitomi,Nakakuki Natsuko,Yasui Yutaka,Suzuki Shoko,Tsuchiya Kaoru,Nakanishi Hiroyuki,Itakura Jun,Takahashi Yuka,Ogawa Shintaro,Tanaka Yasuhito,Asahina Yasuhiro,Izumi Namiki

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus;K Kiyosawa;Hepatology,1990

2. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C;T Poynard;Hepatology,2000

3. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups;T Poynard;Lancet,1997

4. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C;Y Tanaka;Nat Genet,2009

5. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance;D Ge;Nature,2009

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and genetic risk factors for progressive fibrosis in metabolic dysfunction–associated steatotic liver disease;Hepatology Communications;2024-07

2. Treatment Revolution: The New Era Against Hepatitis C;Internal Medicine;2024-06-01

3. Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy;Journal of Viral Hepatitis;2023-01-24

4. Attenuation coefficient (ATT) measurement for liver fat quantification in chronic liver disease;Choonpa Igaku;2023

5. The impact of single‑nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct‑acting antiviral drugs for hepatitis C infection;Biomedical Reports;2021-12-07